Skip to main content
$210.81 -$4.62 (-2.1%)

04:00 PM EDT on 10/06/22

Charles River Laboratories (NYSE:CRL)

CAPS Rating: 2 out of 5

The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.

Current Price $210.81 Mkt Cap $11.0B
Open $214.60 P/E Ratio 25.73
Prev. Close $210.81 Div. (Yield) $0.00 (0.0%)
Daily Range $209.34 - $215.92 Volume 363,278
52-Wk Range $181.36 - $449.34 Avg. Daily Vol. 598,745

Caps

How do you think NYSE:CRL will perform against the market?

Add Stock to CAPS Watchlist

All Players

219 Outperform
13 Underperform
 

All-Star Players

43 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Recent Community Commentary

Read the most recent pitches from players about CRL.

Recs

1
Member Avatar DaytradingStars (37.52) Submitted: 6/14/2020 4:42:09 AM : Outperform Start Price: $179.09 NYSE:CRL Score: -7.49

17 growth for 24 forward

Recs

1
Member Avatar TMFTripleOption (< 20) Submitted: 4/21/2020 11:15:59 PM : Outperform Start Price: $135.30 NYSE:CRL Score: +21.74

Charles River Labs had its hand in 90% of FDA approved drugs last year. They are also building a lot of labs in China. Their demand will only continue to grow.

Recs

1
Member Avatar CMFTomato (61.85) Submitted: 12/15/2019 4:28:09 PM : Outperform Start Price: $123.48 NYSE:CRL Score: +41.97

Charles River breeds and sells lab rats, mice, bunnies, guinea pigs of all shapes and sizes and in various states of sickness, health, obesity, and even already having had various clinical procedures and operations. This company's work is unpleasant, but essential for the clinical trials and research behind the groundbreaking treatments and therapies that allow us to live longer and healthier.

Leaderboard

Find the members with the highest scoring picks in CRL.

Score Leader

tskephart

tskephart (95.86) Score: +525.51

The Score Leader is the player with the highest score across all their picks in CRL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tskephart 95.86 11/26/2008 Outperform 3Y $21.87 +863.92% +338.41% +525.51 1 Comment
dingo72 78.02 12/3/2008 Outperform 3Y $21.94 +860.85% +345.30% +515.55 0 Comment
5st4 88.11 1/9/2009 Outperform NS $23.91 +781.68% +316.62% +465.06 0 Comment
DFT2007 99.90 11/17/2008 Outperform NS $23.35 +802.83% +343.22% +459.60 0 Comment
dog1350 78.07 12/11/2008 Outperform 5Y $24.17 +772.20% +327.57% +444.63 0 Comment
jackjjr 72.22 11/17/2011 Outperform 5Y $28.96 +627.94% +202.83% +425.10 0 Comment
humenay 66.94 12/23/2008 Outperform 3Y $24.67 +754.52% +333.90% +420.62 0 Comment
kagold 84.53 10/4/2011 Outperform 5Y $27.68 +661.60% +244.42% +417.18 0 Comment
CMFGouldberg 56.20 10/3/2011 Outperform 5Y $28.18 +648.08% +239.47% +408.61 0 Comment
elzbal 20.94 10/17/2011 Outperform 1Y $29.43 +616.31% +208.21% +408.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRL.